Exact Sciences Showcases Breadth of Early Detection and Treatment Guidance Portfolio with Multiple Data Presentations at ASCO 2022

/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced new data supporting its cancer tests and...

Related Keywords

Canada ,Illinois ,United States ,Chicago ,America ,American ,Federico Maiardi ,Stephanie Spanos ,Kevin Conroy ,Megan Jones ,Sciences Corp ,Sciences On Facebook ,American Society Of Clinical Oncology ,Linkedin ,Meeting Library ,World Health Organization ,Sciences On Twitter Exactsciences ,Sciences Company ,Nasdaq ,Exchange Commission ,Prnewswire Exact Sciences Corp ,Genomic Health Inc ,Fashion Analytics ,Sciences Corporation ,Clinical Oncology ,Annual Meeting ,Exact Sciences ,Exact Science ,Mayo Clinic ,Oncotype Map ,Pan Cancer Tissue ,Gastrointestinal Cancer ,Hematologic Malignancies ,Chronic Lymphocytic ,Developmental Therapeutics ,Molecularly Targeted Agents ,Breast Cancer ,Lung Cancer ,Non Small Cell ,Risk Reduction ,Genitourinary Cancer ,Recurrence Score ,Prostate Score ,Oncomap Extra ,Genomic Health ,Risk Factors ,Annual Report ,Quarterly Reports ,World Health ,Accessed May ,Latin America ,Exact Sciences Corp ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Otc ,Mallcap ,Clinical Trials Amp Medical Discoveries ,Trade Show News ,